Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromesVirginia O Volpe, Najla Al Ali, Onyee Chan, et al.
Frontiers in Allergy|November 4, 2024
Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptomsMatthew J Hamilton, Loren W Greene, Lauren M Madigan, et al.
Leukemia Research|February 8, 2025
Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML)Zena Komrokji, Najla Al Ali, Zhuoer Xie, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older PatientsMegan Melody, Andrew Kuykendall, David Sallman, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 20, 2025
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease ProgressionLuis E Aguirre, Somedeb Ball, Akriti Jain, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid LeukemiaDasom Lee, Akriti G Jain, Yehuda Deutsch, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 9, 2023
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid LeukemiaAkriti G Jain, Somedeb Ball, Luis E Aguirre, et al.
Haematologica|May 11, 2019
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemiaChetasi Talati, Varun C Dhulipala, Mar Tine Extermann, et al.
Annals of Hematology|September 7, 2024
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemiaAkriti G Jain, Virginia O Volpe, Chen Wang, et al.
Future Oncology (London, England)|March 7, 2026
POIESIS: a phase III study of add-on navtemadlin in JAK inhibitor-naïve myelofibrosis patients with a suboptimal response to ruxolitinibPankit Vachhani, Abdulraheem Yacoub, Raajit Rampal, et al.
Pageof 6